/PRNewswire/ The "Molecular Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. The global market for.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The publisher brings years of research experience to the 9th edition of this report. The 281-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Enteric Disease Testing Market to Reach $4.5 Billion by 2027
Amid the COVID-19 crisis, the global market for Enteric Disease Testing estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$4.5 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027.
Share this article
Share this article
ALBANY, N.Y., Dec. 28, 2020 /PRNewswire/ The growing prevalence of enteric diseases around the world is a vital growth indicator for the enteric disease testing market. Poor sanitation in remote areas and certain parts of emerging economies has led to low levels of hygiene. These factors serve as breeding grounds for enteric diseases. Thus, this aspect will increase the demand for enteric disease testing to a great extent.
Enteric diseases are the type of diseases caused by microscopic pathogens. These pathogens enter the body through the mouth or intestine. They are prominently present in contaminated foods or fluids. The symptoms of enteric diseases are appetite loss, diarrhea, fever, blood in stools, dehydration, and others. The highest fatalities occurred due to enteric diseases are among the geriatric population. Thus, the rising geriatric population may bring sizable growth for the enteric disease testing market.